CASI Pharmaceuticals CASIF Cash Flow Statement (2022-2025)

OTC CASIF
$0.13 +0.00 (+0.00%)
At close: Aug 20, 2026 · 4:00 PM EDT
Cash Flow Statement Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter) -6.96M-6.39M-5.72M-100.47M-7.21M-9.27M-5.09M-64.71M-9.32M-8.65M-8.32M-13.02M-10.30M-11.08M-10.67M-77.55M
Gains from Investment Securities (Quarter) -1.55M-1.15M0.70M-0.05M-0.14M-0.94M0.01M1.86M1.25M-2.46M0.11M-0.02M
Investing Activities
Divestments (Quarter) 2.50M
Financing Activities
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter) 2.30M